Uliolind en es it fr

Uliolind Brand names, Uliolind Analogs

Uliolind Brand Names Mixture

  • No information avaliable

Uliolind Chemical_Formula


Uliolind RX_link


Uliolind fda sheet

Uliolind FDA

Uliolind msds (material safety sheet)

Uliolind MSDS

Uliolind Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Uliolind Molecular Weight

375.864 g/mol

Uliolind Melting Point

151.5 oC

Uliolind H2O Solubility

14 mg/L

Uliolind State


Uliolind LogP


Uliolind Dosage Forms

Injection; Oral solution; Tablet

Uliolind Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Uliolind Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Uliolind Absorption


Uliolind side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Uliolind Patient Information


Uliolind Organisms Affected

Humans and other mammals